Alopecia and mood stabilizers: two case reports.

Détails

ID Serval
serval:BIB_F1B9519B7CEB
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Alopecia and mood stabilizers: two case reports.
Périodique
European archives of psychiatry and clinical neuroscience
Auteur⸱e⸱s
Uehlinger C., Barrelet L., Touabi M., Baumann P.
ISSN
0940-1334 (Print)
ISSN-L
0940-1334
Statut éditorial
Publié
Date de publication
1992
Peer-reviewed
Oui
Volume
242
Numéro
2-3
Pages
85-88
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Publication Status: ppublish
Résumé
Two cases of alopecia observed during treatment with lithium and valproate are described, and the recent literature on this subject is reviewed. Our clinical observations confirm earlier reports. These toxic alopecias are characterized by a diffuse but rarely total hair loss. After stopping medication, the hair grows back generally and completely. Two cases of toxic alopecia are presented where hair grew back following a substitution of lithium by valproate in the first case and after stopping valproate in the second. The evaluation and therapeutic attitude in the presence of alopecia in patients needing mood stabilizers are also discussed.
Mots-clé
Adult, Alopecia/chemically induced, Carbamazepine/adverse effects, Carbamazepine/therapeutic use, Clorazepate Dipotassium/administration & dosage, Clorazepate Dipotassium/therapeutic use, Depressive Disorder/drug therapy, Depressive Disorder/rehabilitation, Female, Fluvoxamine/administration & dosage, Fluvoxamine/therapeutic use, Haloperidol/administration & dosage, Haloperidol/therapeutic use, Hospitalization, Humans, Lithium Carbonate/adverse effects, Lithium Carbonate/blood, Lithium Carbonate/therapeutic use, Methotrimeprazine/administration & dosage, Methotrimeprazine/therapeutic use, Middle Aged, Schizophrenia/drug therapy, Schizophrenia/rehabilitation, Valproic Acid/adverse effects, Valproic Acid/therapeutic use
Pubmed
Web of science
Création de la notice
12/01/2021 17:16
Dernière modification de la notice
15/04/2023 6:51
Données d'usage